Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alphatec Holdings, Inc.ATEC · Entity 4720 | Director | June 10, 2026 | June 12, 2026 |
| ORTHOPEDIATRICS CORPKIDS · Entity 5338 | Director · 10% owner | September 10, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alphatec Holdings, Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 378,839 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 32,012 · Balance 378,839 F1: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. |
| Common StockSEC Table I · non-derivative | IndirectBy Squadron Capital LLC | 10,395,045 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,395,045 F2: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.
F2: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
ORTHOPEDIATRICS CORP
Report date September 10, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 6,201,764 |
Reported balance
After 2026-09-10 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-10 · Sale · Disposed 302,369 · Balance 6,201,764 F1: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | Direct | 44,384 |
Reported balance
Holding disclosure · report date 2026-09-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 44,384 F4: Includes restricted stock awards totaling 17,959 shares. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
F4: Includes restricted stock awards totaling 17,959 shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2026 Filed Sep 10, 2026 20:21 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 302,369 | $21.01 | $6,352,772.69 |
DisclosureSEC source: 0001425450-26-000087 · wk-form4_1789071671.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,201,764 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:26 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 22,500 | $23.35 | $525,375.00 |
DisclosureSEC source: 0001425450-26-000085 · wk-form4_1788553597.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,504,133 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:13 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 10,131 | $23.10 | $234,026.10 |
DisclosureSEC source: 0001425450-26-000083 · wk-form4_1788297228.xml · nonDerivative · entry 2 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,526,633 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 21:13 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 326,700 | $23.04 | $7,527,168.00 |
DisclosureSEC source: 0001425450-26-000083 · wk-form4_1788297228.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,536,764 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| August 26, 2026 Filed Aug 26, 2026 22:17 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 18,000 | $24.28 | $437,040.00 |
DisclosureSEC source: 0001425450-26-000081 · wk-form4_1787782652.xml · nonDerivative · entry 3 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,863,464 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| August 25, 2026 Filed Aug 26, 2026 22:17 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 16,300 | $24.74 | $403,262.00 |
DisclosureSEC source: 0001425450-26-000081 · wk-form4_1787782652.xml · nonDerivative · entry 2 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,881,464 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 22:17 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 4,000 | $25.75 | $103,000.00 |
DisclosureSEC source: 0001425450-26-000081 · wk-form4_1787782652.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,897,764 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 32,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001719217-26-000002 · form4-06122026_050606.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,839 F1 · security: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 13:54 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 11,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-26-000061 · wk-form4_1781099658.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,384 F1 · balance_after: Includes restricted stock awards totaling 17,959 shares. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 00:28 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 250,000 | $19.66 | $4,915,000.00 |
DisclosureSEC source: 0001719217-25-000009 · form4-12192025_121237.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Squadron Capital LLC Disclosed balance after: 10,395,045 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.33 to $19.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 00:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 28,834 | $21.03 | $606,379.02 |
DisclosureSEC source: 0001719217-25-000007 · form4-12102025_071210.xml · nonDerivative · entry 2 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Squadron Capital LLC Disclosed balance after: 10,645,045 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 221,166 | $21.20 | $4,688,719.20 |
DisclosureSEC source: 0001719217-25-000007 · form4-12102025_071210.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Squadron Capital LLC Disclosed balance after: 10,673,879 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 00:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 250,000 | $20.62 | $5,155,000.00 |
DisclosureSEC source: 0001719217-25-000005 · form4-11252025_071103.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Squadron Capital LLC Disclosed balance after: 10,895,045 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.34 to $20.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:36 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 250,000 | $20.80 | $5,200,000.00 |
DisclosureSEC source: 0001719217-25-000003 · form4-11142025_091108.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Squadron Capital LLC Disclosed balance after: 11,145,045 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.67 to $21.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 21:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 15,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017264 · form4-06132025_050607.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,827 F1 · security: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| May 23, 2025 Filed May 28, 2025 12:52 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 8,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000065 · wk-form4_1748436733.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,948 F1 · balance_after: Includes restricted stock awards totaling 10,900 shares. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 20:27 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 16,978 | $5.89 | $100,000.42 |
DisclosureSEC source: 0001415889-24-022226 · form4-08262024_080822.xml · nonDerivative · entry 2 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,696 Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 20:27 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 8,818 | $5.67 | $49,998.06 |
DisclosureSEC source: 0001415889-24-022226 · form4-08262024_080822.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,718 Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 16,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016930 · form4-06142024_040614.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,900 F1 · security: On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:41 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000047 · wk-form4_1717101683.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,547 F1 · balance_after: Includes restricted stock awards totaling 4,640 shares. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 00:05 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 9,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-010124 · form4-06222023_120610.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,153 F1 · security: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 19:32 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000082 · wk-form4_1686857532.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,781 F1 · balance_after: Includes restricted stock awards totaling 3,560 shares. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 20:45 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 3,100 | $15.24 | $47,244.00 |
DisclosureSEC source: 0000899243-23-008574 · doc4.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,245 Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 11:31 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | OtherWarrants (right to buy) · Derivative | 1,525,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-031659 · doc4.xml · derivative · entry 3 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,525,000 shares Expires not disclosed F2 · derivative.exercise_date: Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. F2 · derivative.expiration_date: Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. F1 · ownership.nature: These securities are held directly by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 11:31 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | OtherCommon Stock | 1,525,000 | $0.00 | $457.50 |
DisclosureSEC source: 0000899243-22-031659 · doc4.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,901,764 F1 · ownership.nature: These securities are held directly by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| September 06, 2022 Filed Feb 3, 2023 22:56 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GiftCommon Stock | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003915 · doc5.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,145 Read SEC document |
| September 02, 2022 Filed Feb 3, 2023 22:55 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003913 · doc5.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,816 Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 21:38 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | PurchaseWarrants (right to buy) · Derivative | 1,525,000 | $55.00 Strike: $0.00 | $83,874,695.00 |
DisclosureSEC source: 0000899243-22-028657 · doc4.xml · derivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,525,000 Underlying: Common Stock · 1,525,000 shares Expires not disclosed F1 · derivative.exercise_date: Squadron Capital LLC ("Squadron") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days. F1 · derivative.expiration_date: Squadron Capital LLC ("Squadron") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days. F2 · ownership.nature: These securities are held directly by Squadron. As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003360 · edgar.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,395 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 12:17 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000070 · wf-form4_165425862720437.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,816 F1 · balance_after: Includes restricted stock awards totaling 3,092 shares. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 20:29 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | PurchaseCommon Stock | 825 | $66.48 | $54,846.00 |
DisclosureSEC source: 0001425450-21-000155 · wf-form4_163674896073977.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,125 F1 · shares: Represents shares purchased by Mr. Pelizzon in the open market. F2 · balance_after: Includes restricted stock awards totaling 2,801 shares. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 00:02 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 4,366 | $11.41 | $49,816.06 |
DisclosureSEC source: 0001179110-21-010133 · edgar.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,849 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:38 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 5,425 | $13.00 | $70,525.00 |
DisclosureSEC source: 0001179110-21-010028 · edgar.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,483 Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 22:29 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-025076 · doc4.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,058 F1 · shares: On June 16, 2021, the Issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date. F1 · price: On June 16, 2021, the Issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 18:30 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-21-000097 · wf-form4_162283140859682.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,300 F1 · balance_after: Includes restricted stock awards totaling 2,801 shares. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:25 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 120,000 | $15.25 | $1,830,000.00 |
DisclosureSEC source: 0000899243-21-019280 · doc4.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,837 Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 14:00 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | PurchaseCommon Stock | 3,700 | $46.50 | $172,050.00 |
DisclosureSEC source: 0001425450-21-000053 · wf-form4_161598958771882.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,900 F1 · shares: Represents shares purchased by Mr. Pelizzon in the open market. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:48 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 695 | $15.93 | $11,071.35 |
DisclosureSEC source: 0000899243-21-010986 · doc4.xml · nonDerivative · entry 2 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,837 Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:48 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 4,003 | $15.50 | $62,046.50 |
DisclosureSEC source: 0000899243-21-010986 · doc4.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,142 Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:10 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 8,100,810 | $11.11 | $89,999,999.10 |
DisclosureSEC source: 0000899243-21-009425 · doc4.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Squadron Capital LLC Disclosed balance after: 11,395,045 F1 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:45 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 1,350,135 | $11.11 | $14,999,999.85 |
DisclosureSEC source: 0001179110-20-012195 · edgar.xml · nonDerivative · entry 2 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Squadron Capital LLC Disclosed balance after: 2,437,092 F1 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| October 16, 2020 Filed Jan 26, 2021 19:15 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 857,143 | $8.75 | $7,500,001.25 |
DisclosureSEC source: 0001179110-21-000832 · edgar.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Squadron Capital LLC Disclosed balance after: 3,294,235 F1 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| June 19, 2020 Filed Jun 22, 2020 19:22 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,340 | $30.97 Strike: $30.97 | $41,499.80 |
DisclosureSEC source: 0001425450-20-000093 · wf-form4_159285370887898.xml · derivative · entry 3 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,340 shares Expires 2022-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F3 · ownership.nature: These shares of Common Stock and stock option are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares of Common Stock and stock option. The reporting person expressly disclaims beneficial ownership of these shares of Common Stock and stock option, except to the extent of his pecuniary interest therein. The inclusion of these shares of Common Stock and stock option in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| June 19, 2020 Filed Jun 22, 2020 19:22 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionCommon Stock | 1,340 | $30.97 | $41,499.80 |
DisclosureSEC source: 0001425450-20-000093 · wf-form4_159285370887898.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,376,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 21:08 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 21,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007647 · edgar.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,139 F1 · security: On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date. F1 · shares: On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date. F1 · price: On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date. F1 · balance_after: On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 19:34 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-20-000077 · wf-form4_159129923744914.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,200 F1 · balance_after: Includes restricted stock awards totaling 2,801 shares. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 19:04 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-19-000065 · wf-form4_155993426688429.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,800 F1 · balance_after: Includes restricted stock awards totaling 2,334 shares. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 21:01 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-18-000086 · wf-form4_152970125333171.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,400 F1 · balance_after: Includes restricted stock awards totaling 1,400 shares. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:44 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | PurchaseCommon Stock | 2,000 | $19.50 | $39,000.00 |
DisclosureSEC source: 0001425450-18-000072 · wf-form4_152718742764554.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 F1 · shares: Represents shares purchased by Mr. Pelizzon in the open market. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 21:09 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | PurchaseCommon Stock | 1,000 | $17.50 | $17,500.00 |
DisclosureSEC source: 0001425450-18-000037 · wf-form4_152097534718300.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 F1 · shares: Represents shares that were purchased by Mr. Pelizzon in the open market. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.